In Vivo Bacteriophage Biodistribution - Institut Pasteur Access content directly
Book Sections Year : 2018

In Vivo Bacteriophage Biodistribution


At the dawn of the renaissance of bacteriophage therapy, the full acceptation of bacteriophages as anti-bacterial agents requires the determination of their basic pharmacokinetic parameters. Such data, known for all conventional drugs used in human and veterinary medicine, allow optimizing dose regimens, efficacy, and help to limit toxicity. Here, we describe basic methods to experimentally obtain pharmacokinetic data and give also examples of data calculation to determine key parameters related to the biodistribution and elimination of bacteriophages in vivo.
No file

Dates and versions

pasteur-03164482 , version 1 (09-03-2021)



Nicolas Dufour, Raphaëlle Delattre, Laurent Debarbieux. In Vivo Bacteriophage Biodistribution. Joana AZEREDO, Sanna SILLANKORVA. Bacteriophage Therapy. From Lab to Clinical Practice, 1683, Springer Protocols, pp.123-137, 2018, Methods in Molecular Biology, 978-1-4939-7395-8. ⟨10.1007/978-1-4939-7395-8_11⟩. ⟨pasteur-03164482⟩
24 View
2 Download



Gmail Mastodon Facebook X LinkedIn More